PortfoliosLab logoPortfoliosLab logo
GLOB vs. CI
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

GLOB vs. CI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Globant S.A. (GLOB) and Cigna Corporation (CI). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, GLOB achieves a -39.31% return, which is significantly lower than CI's -1.09% return. Over the past 10 years, GLOB has underperformed CI with an annualized return of 0.34%, while CI has yielded a comparatively higher 8.67% annualized return.


GLOB

1D
-6.17%
1M
-1.27%
YTD
-39.31%
6M
-42.85%
1Y
-58.93%
3Y*
-40.53%
5Y*
-28.57%
10Y*
0.34%

CI

1D
-0.73%
1M
-3.09%
YTD
-1.09%
6M
1.27%
1Y
-11.72%
3Y*
3.66%
5Y*
3.21%
10Y*
8.67%
*Multi-year figures are annualized to reflect compound growth (CAGR)

GLOB vs. CI - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
GLOB
Globant S.A.
-39.31%-69.51%-9.90%41.52%-46.46%44.34%105.20%88.30%21.22%39.31%
CI
Cigna Corporation
-1.09%1.72%-6.27%-7.97%46.68%12.29%1.83%7.70%-6.46%52.29%

Correlation

The correlation between GLOB and CI is 0.10, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.10

Correlation (3Y)
Calculated over the trailing 3-year period

0.06

Correlation (5Y)
Calculated over the trailing 5-year period

0.09

Correlation (10Y)
Calculated over the trailing 10-year period

0.13

Correlation (All Time)
Calculated using the full available price history since Jul 21, 2014

0.14

Fundamentals

Market Cap

GLOB:

$1.72B

CI:

$71.48B

EPS

GLOB:

$2.45

CI:

$23.59

PE Ratio

GLOB:

16.16

CI:

11.48

PEG Ratio

GLOB:

3.31

CI:

0.66

PS Ratio

GLOB:

0.72

CI:

0.26

PB Ratio

GLOB:

0.81

CI:

1.69

Total Revenue (TTM)

GLOB:

$2.45B

CI:

$277.94B

Gross Profit (TTM)

GLOB:

$800.13M

CI:

$19.38B

EBITDA (TTM)

GLOB:

$335.92M

CI:

$10.03B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

GLOB vs. CI — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

GLOB
GLOB Risk / Return Rank: 66
Overall Rank
GLOB Sharpe Ratio Rank: 33
Sharpe Ratio Rank
GLOB Sortino Ratio Rank: 44
Sortino Ratio Rank
GLOB Omega Ratio Rank: 55
Omega Ratio Rank
GLOB Calmar Ratio Rank: 77
Calmar Ratio Rank
GLOB Martin Ratio Rank: 88
Martin Ratio Rank

CI
CI Risk / Return Rank: 2525
Overall Rank
CI Sharpe Ratio Rank: 2525
Sharpe Ratio Rank
CI Sortino Ratio Rank: 2424
Sortino Ratio Rank
CI Omega Ratio Rank: 2323
Omega Ratio Rank
CI Calmar Ratio Rank: 2626
Calmar Ratio Rank
CI Martin Ratio Rank: 2525
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

GLOB vs. CI - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Globant S.A. (GLOB) and Cigna Corporation (CI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


GLOBCIDifference
Sharpe ratioReturn per unit of total volatility

-0.71

Sortino ratioReturn per unit of downside risk

-1.48

Omega ratioGain probability vs. loss probability

0.80

0.96

-0.17

Calmar ratioReturn relative to maximum drawdown

-0.87

-0.44

-0.42

Martin ratioReturn relative to average drawdown

-1.39

-0.81

-0.58

GLOB vs. CI - Sharpe Ratio Comparison

The current GLOB Sharpe Ratio is -1.07, which is lower than the CI Sharpe Ratio of -0.36. The chart below compares the historical Sharpe Ratios of GLOB and CI, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


GLOBCIDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-1.07

-0.36

-0.71

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.56

0.11

-0.67

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.01

0.28

-0.28

Sharpe Ratio (All Time)

Calculated using the full available price history

0.24

0.34

-0.10

Drawdowns

GLOB vs. CI - Drawdown Comparison

The maximum GLOB drawdown since its inception was -90.76%, which is greater than CI's maximum drawdown of -84.34%. Use the drawdown chart below to compare losses from any high point for GLOB and CI.


Loading charts...

Drawdown Indicators


GLOBCIDifference

Max Drawdown

Largest peak-to-trough decline

-90.76%

-84.34%

-6.42%

Max Drawdown (1Y)

Largest decline over 1 year

-68.29%

-26.54%

-41.75%

Max Drawdown (3Y)

Largest decline over 3 years

-86.88%

-32.10%

-54.78%

Max Drawdown (5Y)

Largest decline over 5 years

-90.76%

-32.10%

-58.66%

Max Drawdown (10Y)

Largest decline over 10 years

-90.76%

-42.47%

-48.29%

Current Drawdown

Current decline from peak

-88.81%

-23.95%

-64.86%

Average Drawdown

Average peak-to-trough decline

-26.00%

-18.82%

-7.18%

Ulcer Index

Depth and duration of drawdowns from previous peaks

42.45%

14.47%

+27.98%

Volatility

GLOB vs. CI - Volatility Comparison

Globant S.A. (GLOB) has a higher volatility of 24.04% compared to Cigna Corporation (CI) at 8.14%. This indicates that GLOB's price experiences larger fluctuations and is considered to be riskier than CI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


GLOBCIDifference

Volatility (1M)

Calculated over the trailing 1-month period

24.04%

8.14%

+15.90%

Volatility (6M)

Calculated over the trailing 6-month period

44.44%

18.19%

+26.25%

Volatility (1Y)

Calculated over the trailing 1-year period

55.08%

32.75%

+22.33%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

51.30%

28.35%

+22.95%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

47.53%

30.71%

+16.82%

Dividends

GLOB vs. CI - Dividend Comparison

GLOB has not paid dividends to shareholders, while CI's dividend yield for the trailing twelve months is around 1.69%.


PositionTTM20252024202320222021202020192018201720162015
CI
Cigna Corporation
1.69%2.19%2.03%1.64%1.35%1.74%0.02%0.02%0.02%0.02%0.03%0.03%
GLOB
Globant S.A.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

GLOB vs. CI - Financials Comparison

This section allows you to compare key financial metrics between Globant S.A. and Cigna Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00B40.00B60.00B80.00B20222023202420252026
607.09M
68.49B
(GLOB) Total Revenue
(CI) Total Revenue
Values in USD except per share items

GLOB vs. CI - Profitability Comparison

The chart below illustrates the profitability comparison between Globant S.A. and Cigna Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%10.0%20.0%30.0%40.0%20222023202420252026
30.1%
0
Portfolio components
GLOB - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Globant S.A. reported a gross profit of 182.94M and revenue of 607.09M. Therefore, the gross margin over that period was 30.1%.

CI - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Cigna Corporation reported a gross profit of 0.00 and revenue of 68.49B. Therefore, the gross margin over that period was 0.0%.

GLOB - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Globant S.A. reported an operating income of 55.49M and revenue of 607.09M, resulting in an operating margin of 9.1%.

CI - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Cigna Corporation reported an operating income of 2.36B and revenue of 68.49B, resulting in an operating margin of 3.4%.

GLOB - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Globant S.A. reported a net income of 36.98M and revenue of 607.09M, resulting in a net margin of 6.1%.

CI - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Cigna Corporation reported a net income of 1.65B and revenue of 68.49B, resulting in a net margin of 2.4%.


Frequently Asked Questions


GLOB and CI have a correlation of 0.10, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

GLOB has higher volatility (24.04%) compared to CI (8.14%). In terms of maximum drawdown, GLOB dropped -90.76% vs CI's -84.34%.

CI currently has the higher Sharpe Ratio (-0.36 vs -1.07), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for GLOB and CI

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer